Our purpose
Reimagine medicine to improve and extend people's lives.
Our vision
Become the most valued and trusted medicines company in the world.
Our strategy
Deliver high value medicines that help to alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
Our footprint
5.1b
Total contribution of R&D activities to US Gross Domestic Product (GDP)
17,000+
Employees in the US from coast to coast
33%
Growth in patient reach in 2024 (across 7 focus brands)
We focus on core therapeutic areas with high unmet patient needs
Cardiovascular, renal and metabolic
Transforming how the world tackles cardiovascular disease and delivering new treatments for people living with chronic kidney disease.
Immunology
Working to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
and technology platforms that enable cutting-edge innovative therapies
Chemistry
Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized for medicines.
Biotherapeutics
Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.
xRNA
RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.
while keeping committed to our patients
Read more about our access principles, patient assistance programs, and commitment to enhancing diverse patient representation in clinical trials to improve scientific insights based on real world-demographics of patients who will eventually take our medicines.